VPIM
CNMD icon

Vanguard Personalized Indexing Management’s CONMED CNMD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,197
Closed -$241K – 1638
2023
Q4 		$241K Sell
2,197
-98
-4% -$10.1K 0.01% 1328
2023
Q3 		$231K Buy
2,295
+308
+16% +$35.4K 0.01% 1232
2023
Q2 		$270K Buy
+1,987
New +$243K 0.01% 1188

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Personalized Indexing Management's CNMD Position: Q1 2024 in Review

Vanguard Personalized Indexing Management sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,197 shares — an estimated $241K sold.

Vanguard Personalized Indexing Management first reported a position in CNMD in Q2 2023 and held it in 3 quarters. The position peaked at $270K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Vanguard Personalized Indexing Management reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 2,197 CONMED shares in Q1 2024, an estimated $241K.
  • Vanguard Personalized Indexing Management first reported a position in CONMED in Q2 2023 and held it in 3 quarters.
  • Vanguard Personalized Indexing Management's CONMED position peaked at $270K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2024, filed 9 May 2024.